Research output per year
Research output per year
Personal profile
Curriculum
Education
2001: M.D, University of Southern Denmark, Denmark
Academic Degrees and Appointments
2008: Ph.D, University of Southern Denmark, Denmark. ”The JAK2 V617F mutation in Philadelphia chromosome negative chronic myeloproliferative disorders – Impact on clinical phenotype”.
2004-2007: Research Fellow at University of Southern Denmark, Denmark
Clinical Appointments
2001-2003 Resident. Sygehus Fyn Svendborg-Faaborg, Denmark
2003-2004 House Officer. Dept. of Hematology,Odense University Hospital, Denmark.
2008: Senior House Officer. Dept. of Hematology, Odense University Hospital, Denmark.
2008- 2010: Senior House Officer. Dept. of Internal medicine, Vejle Hospital, Denmark
2010 - 2013: Senior House Officer. Dept. of Hematology, Odense University Hospital, Denmark
2013 - Consultant. Dept. of Haematology, Odense University Hospital, Denmark
Academic Appointments
2013 – Associate Professor of Haematology, Faculty of Medical Sciences, University of Southern Denmark
Relevant positions
Member of the Danish Society of Hematology
Member of board, Danish Studygroup on Chronic Myeloid Disease (DSKMS)
Member of the Nordic MPD Study Group.
Member of European Cooperation in Science and Technology (COST) Biomedicin and
Molecular Biosciences (BMBS) action BM0902 on MPD.
Member of Recommendation board on stem cell transplantation, Danish Society of Hematology.
Head of Board, Danish committee on autologous stem cell transplantation and high dose therapy, Danish Society of Hematology
Member of AgeCare (Academy of Geriatric Cancer Research). An Elite Research
Center at Odense University Hospital
Fingerprint
Dive into the research topics where Thomas Stauffer Larsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphoma
Jelicic, J., Juul-Jensen, K., Bukumiric, Z., Runason Simonsen, M., Roost Clausen, M., Ludvigsen Al-Mashhadi, A., Schou Pedersen, R., Poulsen, C. B., Gang, A. O., Brown, P., El-Galaly, T. C. & Stauffer Larsen, T., Jan 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 1, p. e62-e76Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile -
A Real-World Data-Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B-Cell Lymphoma Patients
Jelicic, J., Juul-Jensen, K., Bukumiric, Z., Runason Simonsen, M., Roost Clausen, M., Ludvigsen Al-Mashhadi, A., Schou Pedersen, R., Bjørn Poulsen, C., Ortved Gang, A., Brown, P., El-Galaly, T. & Stauffer Larsen, T., Jan 2025, In: European Journal of Haematology. 114, 1, p. 26-36Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile21 Downloads (Pure) -
Biomarker-adapted treatment in high-risk large B-cell lymphoma
Leppä, S., Meriranta, L., Arffman, M., Jørgensen, J., Karjalainen-Lindsberg, M. L., Beiske, K., Pedersen, M., Drott, K., Pasanen, A., Karihtala, K., Mannisto, S., Wold, B., Brodtkorb, M., Fagerli, U. M., Larsen, T. S., Munksgaard, L., Sunela, K., Fluge, Ø., Jyrkkiö, S. & Brown, P. & 1 others, , May 2025, In: HemaSphere. 9, 5, 14 p., e70139.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile15 Downloads (Pure) -
CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab
Duell, J., Arias, D. A., Klapper, W., Reinke, S., Eisele, F., Larsen, T. S., Topp, M. S., Rumberger, B., Kim, T., Rosenwald, A. & Rauert-Wunderlich, H., 3. Nov 2025.Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review
-
CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab
Duell, J., Arias, D. A., Klapper, W., Reinke, S., Eisele, F., Larsen, T. S., Topp, M. S., Rumberger, B., Kim, T., Rosenwald, A. & Rauert-Wunderlich, H., 3. Nov 2025, In: Blood. 146, Suppl. 1, 5515.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access
Activities
-
67th American Society of Hematology: Annual Meeting (Event)
Larsen, T. S. (Peer reviewer)
6. Dec 2025 → 9. Dec 2025Activity: Editorial work and peer review › Peer review of manuscripts › Research
-
Challenges in comparing outcomes of frontline clinical trials for diffuse large B-cell lymphoma patients selected based on the international prognostic index: A real-world analysis from the danish lymphoma registry
Jelicic, J. (Speaker), Juul-Jensen, K. (Co-author), Bukumiric, Z. (Co-author), Rask Kragh Jørgensen, R. R. K. J. (Co-author), Runason Simonsen, M. (Co-author), Clausen, M. R. (Co-author), AL-Mashhadi, A. L. (Co-author), Schou Pedersen, R. (Co-author), Bjørn Poulsen, C. (Co-author), Ortved Gang, A. (Co-author), Brown, P. D. N. (Co-author), El-Galaly, T. C. (Co-author) & Larsen, T. S. (Co-author)
Dec 2025Activity: Talks and presentations › Conference presentations
-
Bridging the Spectrum: Laboratory Science, Epidemiology, and the Rise of Cellular Immunotherapy in Lymphoma Care
Larsen, T. S. (Guest lecturer)
19. Sept 2025Activity: Talks and presentations › Conference presentations
-
The Odense Academic CAR T Program
Larsen, T. S. (Guest lecturer)
10. Sept 2025Activity: Talks and presentations › Conference presentations
-
Ph.d.-bedømmelsesudvalg (Event)
Larsen, T. S. (Member)
27. Jun 2025Activity: Membership › Membership of review committee
Press/Media
-
Wrap-up fra ASH 2025: Her er de studier, der vil få indflydelse på dansk klinisk praksis
19/12/2025
1 Media contribution
Press/Media: Press / Media
-
Wrap-up fra ASH 2025: Her er de studier, der vil få indflydelse på dansk klinisk praksis
18/12/2025
1 Media contribution
Press/Media: Press / Media
-
Targeteret induktionsterapi kan få en rolle i fremtidens behandling af PCNSL
10/12/2025
1 Media contribution
Press/Media: Press / Media
-
Bispecifik CAR-T fører til CR hos tre ud af fem ældre NTE-patienter med LBCL
10/12/2025
1 Media contribution
Press/Media: Press / Media
-
Professor om nyt triplet-regime til fremskreden FL: Overraskende flotte resultater
09/12/2025
1 Media contribution
Press/Media: Press / Media
Teaching & Supervision
-
Hovedvejleder, ph.d.-afhandling
Larsen, T. S. 06/06/2025 → 06/06/2025
Course: Teaching and supervision › Supervision